Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy
ISICA-13
ISICA-13
Sponsor study identifier
interventional
400
1 country
1
Study Start
October 2013
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2016
Actual (reported)Study Completion
September 2016
Actual (reported)The purpose of this study is to determine whether extended information given to patients with contact allergy improves knowledge, treatment efficacy and daily functioning.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2016
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 20, 2013
Actual (reported)October 2013
Date type not reportedThis date has not been verified as actual or estimated.
October 1, 2013
Actual (reported)September 2016
Actual (reported)September 2016
Actual (reported)knowledge
knowledge about specific contact allergies and exposure, assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.
one year after inclusion
clinical improvement
one year after inclusion
quality of life
one year after inclusion
effect on daily functioning
one year after inclusion
Extended information on specific allergy
Information according to clinical routine
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Hudmottagningen SUS
Lund, Skåne County, 22185, Sweden
Mossing K, Dizdarevic A, Svensson A, Sonesson A. Impact on quality of life of an intervention providing additional information to patients with allergic contact dermatitis; a randomized clinical trial. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):2166-2171. doi: 10.1111/jdv.18412. Epub 2022 Jul 18.
Andreas Sonesson, MD PhD
Region Skåne, Hudkliniken SUS
400 participants (actual enrollment reported by the registry).
First Submitted
September 20, 2013
First Posted
October 1, 2013
Study Start
October 2013
Date type not reportedThis date has not been verified as actual or estimated.
Epidemiology and Co-Reactivity of Novel Surfactant Allergens
Contact the study team to confirm eligibility.
Primary Completion
September 2016
Actual (reported)Study Completion
September 2016
Actual (reported)Last Updated
April 12, 2017
Record last verified: 2017-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: